Exelixis
EXEL
#1645
Rank
ยฃ7.50 B
Marketcap
ยฃ27.22
Share price
0.11%
Change (1 day)
50.52%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company